Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02097888
Other study ID # KSBLB: 252/11
Secondary ID
Status Recruiting
Phase N/A
First received March 19, 2014
Last updated March 24, 2014
Start date December 2011
Est. completion date December 2014

Study information

Verified date March 2014
Source Kantonsspital Baselland Bruderholz
Contact Sandrine Meyer-Monard, PD Dr. med.
Phone 041 61 436 22 03
Email sandrine.meyer@ksbl.ch
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Observational

Clinical Trial Summary

This will be a prospective observational study. The investigators will compare Erythropoietin (Epo) levels, erythropoiesis, and regulators of erythropoiesis, bone imaging and bone metabolism in healthy volunteers living at different altitudes.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- healthy men and non-pregnant women, ages =18-40 years and = 60 years living in the predefined area

- Exclusion Criteria:

- Known bone pathology including osteoporosis, known haematological disease, known renal disease, heart insufficiency, pulmonal disease

- pregnancy

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Healthy Men and Non- Pregnant Women

Locations

Country Name City State
Switzerland Kantonsspital Baselland / Bruderholz Bruderholz

Sponsors (1)

Lead Sponsor Collaborator
Kantonsspital Baselland Bruderholz

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference of EPO level between control groups up to 4 years No